SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (2564)2/2/2000 10:58:00 AM
From: Walter Morton  Read Replies (1) of 2742
 
I found this on PennyPI.com:

TITLE OF INVENTION: IL-1 Muteins: Their Preparations and Method of Use to Inhibit IL-1 Activity

ENCAPSULATED IMMUNOMODULATORS USEFUL AS VACCINE ADJUVANTS
patents.ibm.com

Encapsulation of IL-1b and Vaccine Experiment:

This investigation employed four groups of female Sprague-Dawley rats. The investigation was for 58 days and the purpose was to evaluate the use of IL-1b as an adjuvant. The vaccine used for these experiments was influenza A/beijing H3N3 (Parke Davis). Each animal?s weight was recored prior to dosing on day 0, and then animals were administered 100 microliters of a sample comprising liposome encapsulated IL-1b intramuscularly. Thereafter, the animals were reweighed and their weight recorded every seven days prior to their blood being drawn for the duration of the study. On day 30, animals were administered a booster dose of the test sample. Blood was collected on days 0, 7, 14, 28, 37,and 58 for determining serum 1gG ELISA titers. Animals were observed daily for sickness or mortality. On day 58, the rats were weighed and euthanized.

Groups:

1. Influenza A/Beijing H3N3 vaccine mixed with IL-1b (no encapsulation)
2. Influenza A/Beijing H3N3 vaccine alone (no encapsulation)
3. Influenza A/Beijing H3N3 vaccine and mature IL-1b encapsulated togeter in liposomes

RESULTS: Animals receiving the liposome encapsulated IL-1b mixed with influenza A/Beijing H3N3 vaccine showed a significant increase in anti-influenza A antibody titer over those animals receiving vaccine alone or non-encapsulated vaccine/IL-1b.

___________

This seems to be news to me. Did you already know about this?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext